Log in to search using one of your social media accounts:

 

CHMP Backs Two Drugs for Opioid Abuse CHMP Backs Two Drugs for Opioid Abuse
The EMA committee recommends naloxone nasal spray (Nyxoid) for treatment of opioid overdose and buprenorphine plus naloxone sublingual tablets (Zubsolv) for treatment of opioid dependence.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2017 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news

Addressing stigma in medication treatment of adolescents with opioid use disorder - Bagley SM, Hadland SE, Carney BL, Saitz R.
: In September 2016, the American Academic of Pediatrics released a policy statement that adolescents with opioid use disorder should be offered pharmacotherapy with buprenorphine/naloxone, methadone, or naltrexone. In our clinical practice, however, we ha... (Source: SafetyLit)
Source: SafetyLit - August 7, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Rapid Growth in Medicaid Spending on Medications to Treat Opioid Use Disorder and Overdose (June 2017)
Report used state Medicaid drug utilization files from 2011 to 2016 to assess spending on buprenorphine, naltrexone, and naloxone prescriptions. (Source: HSR Information Central)
Source: HSR Information Central - July 11, 2017 Category: International Medicine & Public Health Source Type: news

Heroin Addiction: How My Father Saved Me
I was a breech birth ― feet first, my head got stuck in the birth canal. My father brought me to Children’s Hospital in Boston. The doctors diagnosed me with Cerebral Palsy. They told him that the loss of oxygen to my brain had destroyed a portion of the frontal lobe. But my father was a tough Irish Catholic, old-school warrior. He refused to listen to them. No son of his was going to be a cripple. He found a doctor that told him how he could take the place of my injured brain. Every day, he laid me on the floor and exercised my legs. The muscles in my right leg were all shrunken and twisted. His job was to straigh...
Source: Healthy Living - The Huffington Post - June 16, 2017 Category: Consumer Health News Source Type: news

'All Scientific Hands On Deck' To End The Opioid Crisis
By Nora Volkow (Director, NIDA) and Francis Collins (Director, NIH) In 2015, 2 million people had a prescription opioid use disorder and 591,000 suffered from a heroin use disorder; prescription drug misuse alone cost the nation $78.5 billion in health care, law enforcement, and lost productivity. But while the scope of the crisis is staggering, it is not hopeless. We understand opioid addiction better than many other drug use disorders; there are effective strategies that can be implemented right now to save lives and to prevent and treat opioid addiction. At the National Rx Drug Abuse and Heroin Summit in Atlanta, GA las...
Source: Healthy Living - The Huffington Post - June 1, 2017 Category: Consumer Health News Source Type: news

Trump's Approach To The Opioid Epidemic: Neglect Treatment, Ignore The Experts
WASHINGTON – Since taking office, President Donald Trump has systematically removed or limited the power of federal officials and government offices that have the expertise to confront the nation’s opioid epidemic. Trump asked Surgeon General Vivek Murthy to resign in late April. He still has an acting director running the Centers for Disease Control and Prevention. Although he backtracked on his reported plan to essentially gut his Office of National Drug Control Policy, staffers would be wise to polish their resumes.  Trump’s new budget proposal cuts all federal drug prevention programs by roughly...
Source: Healthy Living - The Huffington Post - May 24, 2017 Category: Consumer Health News Source Type: news

FDA OKs Bunavail for Induction of Opioid Addiction Treatment FDA OKs Bunavail for Induction of Opioid Addiction Treatment
The FDA has broadened the indication for Bunavail (buprenorphine and naloxone) buccal film to include induction of buprenorphine treatment for opioid dependence.FDA Approvals (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - May 2, 2017 Category: Psychiatry Tags: Pharmacist News Alert Source Type: news

FDA OKs BioDelivery Sciences ’ Bunavail opioid dependence film
BioDelivery Sciences International (NSDQ:BDSI) said today that the FDA approved a supplemental new drug application for its Bunavail buprenorphine and naloxone buccal film. The revised indication allows patients to use the product to initiate buprenorphine treatment for opioid dependence. Induction is the initial process by which a patient transitions from abusing an opioid to buprenorphine treatment which is designed to relieve cravings and withdrawal, according to BioDelivery Sciences. Get the full story at our sister site, Drug Delivery Business News. The post FDA OKs BioDelivery Sciences’ Bunavail opioid dependen...
Source: Mass Device - May 2, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Wall Street Beat BioDelivery Sciences International Source Type: news

These Are The 2 Key Ways People Get Hooked On Prescription Opioids
This reporting is brought to you by HuffPost’s health and science platform, The Scope. Like us on Facebook and Twitter and tell us your story: scopestories@huffingtonpost.com.  -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - March 23, 2017 Category: Consumer Health News Source Type: news

ARS adding clinics, prescribers to meet opioid treatment demand
Accessible Recovery Services, a Pittsburgh-based network of a dozen medically assisted opioid treatment clinics across the state, said it plans to add six more sites and dozens of "extenders" — nurse practitioners and physician assistants able to prescribe drugs like buprenorphine — in the next three to four months to meet demand. Dr. Frank Kunkel, president and CEO of ARS, said the clinics serve roughly 7,000 patients per year, providing access to drugs like suboxone and buprenorph ine, opioids… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 23, 2017 Category: Biotechnology Authors: Lydia Nuzum Source Type: news

Hardly Any Teens Receive Effective Treatment For Opioid Addiction
(Reuters Health) - Just a small fraction of adolescents with opioid addiction will receive medications that can help them quit, new research shows. These medications, usually methadone or suboxone, are prescribed to reduce craving for opiates and ease withdrawal symptoms, and studies show they help opiate users to abstain. In 2016, the American Academy of Pediatrics advised doctors to consider medication-assisted treatment, specifically suboxone, for adolescents with “severe opioid use disorders.” To get a “baseline” sense of medication-assisted treatment in adolescents with opiate or heroin addicti...
Source: Healthy Living - The Huffington Post - March 13, 2017 Category: Consumer Health News Source Type: news

Obamacare Repeal Could Cripple Efforts To Combat The Opioid Epidemic
WASHINGTON ― Repealing the Affordable Care Act would deal a major blow to efforts to fight addiction in one of the states hardest hit by the opioid epidemic, according to a new study from Harvard Medical School and New York University. Across the country, some four million Americans with addictions or mental health disorders could lose their health insurance, greatly diminishing access to life-saving treatments, the researchers found. In Kentucky, the effects of ACA repeal would be especially devastating. The end of Obamacare could cost Kentucky more than 44 percent of its funding for medication-assisted treatm...
Source: Healthy Living - The Huffington Post - February 14, 2017 Category: Consumer Health News Source Type: news

Inside a Killer Drug Epidemic: A Look at America ’ s Opioid Crisis
The opioid epidemic killed more than 33,000 people in 2015. What follows are stories of a national affliction that has swept the country, from cities on the West Coast to bedroom communities in the Northeast. (Source: NYT Health)
Source: NYT Health - January 6, 2017 Category: Consumer Health News Tags: Heroin Addiction (Psychology) Buprenorphine (Drug) Naloxone (Drug) Sinaloa Cartel Seattle (Wash) Milwaukee (Wis) Iowa New England States (US) Utah Source Type: news

Snapshots of an Epidemic: A Look at the Opioid Crisis Across the Country
The opioid epidemic killed more than 33,000 people in 2015. What follows are stories of a national affliction that has swept the country, from cities on the West Coast to bedroom communities in the Northeast. (Source: NYT Health)
Source: NYT Health - January 6, 2017 Category: Consumer Health News Tags: Heroin Addiction (Psychology) Buprenorphine (Drug) Naloxone (Drug) Sinaloa Cartel Seattle (Wash) Milwaukee (Wis) Iowa New England States (US) Utah Source Type: news

Orexo Appeals Zubsolv(R) US District Court Decision
UPPSALA, Sweden, Dec 8, 2016 -- (Healthcare Sales & Marketing Network) -- Orexo AB (publ.) announces that it has appealed the decision rendered by the United States District Court for the District of Delaware on November 15, 2016 regarding the validity of... Biopharmaceuticals, Generics, Litigation Orexo, Zubsolv, buprenorphine, naloxone, Actavis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 8, 2016 Category: Pharmaceuticals Source Type: news

At the Frontline of the Opioid Epidemic, but Unable to Help
People seek out the emergency room to get painkillers, but the E.R. remains one of the hardest places to get help for an addiction. (Source: NYT Health)
Source: NYT Health - November 10, 2016 Category: Consumer Health News Authors: HELEN OUYANG, M.D. Tags: Addiction (Psychology) Pain-Relieving Drugs Emergency Medical Treatment Drug Abuse and Traffic Hospitals Buprenorphine (Drug) Naloxone (Drug) OxyContin (Drug) Source Type: news

Houston Concierge Medicine Now Offering Outpatient Drug Rehab...
Houston Concierge Medicine and Wellness is now offering outpatient drug rehab therapy with Suboxone. The therapy is highly effective for helping patients who want to get off of opiates as an...(PRWeb November 03, 2016)Read the full story at http://www.prweb.com/releases/suboxonedoctorshouston/outpatientdrugrehab/prweb13821692.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 3, 2016 Category: Pharmaceuticals Source Type: news

U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)
MORRISTOWN, N.J., Oct. 6, 2016 -- (Healthcare Sales & Marketing Network) -- Orexo US announced today that the U.S. Food and Drug Administration (FDA) has approved ZUBSOLV® (buprenorphine/naloxone CIII sublingual tablet) 0.7mg/0.18mg for the treatment ... Biopharmaceuticals, FDA Orexo, ZUBSOLV, buprenorphine, naloxone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 6, 2016 Category: Pharmaceuticals Source Type: news

Canadian Doctors Can Now Prescribe Heroin
Canadian doctors can now prescribe heroin to people with serious addictions to the drug. This change is thanks to new regulations approved earlier this month by the Canadian government. The government says this treatment will be limited to a small number of users "in cases where traditional options have been tried and proven ineffective." Doctors will need to apply to Health Canada -- the country's health department -- for access to pharmaceutical grade heroin (diacetylmorphine). Requests will be approved on a case-by-case basis as part of the government-run Special Access Programme. Shift in approach This ...
Source: Healthy Living - The Huffington Post - September 27, 2016 Category: Consumer Health News Source Type: news

35 States File'Product Hopping' Lawsuit Against Indivior
British opiod drugmaker Indivior is facing lawsuits from 35 U.S. states alleging it employed a product hopping strategy to keep generic versions of Suboxone off the market. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 24, 2016 Category: Pharmaceuticals Source Type: news

States sue Suboxone drugmaker
A lawsuit filed by 35 states and the District of Columbia alleges that drugmaker Indivior violated antitrust laws by trying to extend its monopoly over Suboxone, New York's attorney general announced Thursday. Suboxone is a prescription drug used to treat patients addicted to heroin, painkillers and other opioid drugs. (Source: CNN.com - Health)
Source: CNN.com - Health - September 23, 2016 Category: Consumer Health News Source Type: news

Suboxone maker sued by U.S. states alleging anticompetitive practices
35 U.S. states and District of Columbia file an antitrust lawsuit alleging that British drugmaker Indivior tried to keep cheaper, generic versions of Suboxone off the market. (Source: CBC | Health)
Source: CBC | Health - September 23, 2016 Category: Consumer Health News Tags: News/Health Source Type: news

Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
PHILADELPHIA, Sept. 20, 2016 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Buprenorphi... Biopharmaceuticals, Generics, FDA Lannett, Buprenorphine, Naloxone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 20, 2016 Category: Pharmaceuticals Source Type: news

Dependence on over the counter (OTC) codeine containing analgesics: treatment and recovery with buprenorphine naloxone - Hout MCV, Delargy I, Ryan G, Flanagan S, Gallagher H.
We present a clinical case series of four adult patients dependent on OTC codeine combination analgesics in Ireland. Cases (... (Source: SafetyLit)
Source: SafetyLit - September 19, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Physician efforts to reverse opioid epidemic quantified
When patients present with issues, physicians look to the most effective tools for treatment. The same is true in addressing an epidemic. While much more work remains to reverse the nation ’s opioid epidemic, using tools such as prescription drug monitoring programs (PDMP), medication-assisted treatment and naloxone, physicians are making progress. A new fact sheet provides some evidence of that progress on a number of fronts.Focused prescribing practices In a fact sheet released by the AMA,physicians ’ progress to reverse the nation’s opioid epidemic was quantified showing new trends in the use of avail...
Source: AMA Wire - September 14, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news

HHS: Medication Assisted Treatment for Opioid Use Disorders; Correction
Correction made to afinal rule that appeared in the Federal Register on July 8, 2016 regarding increased access to treatment with buprenorphine and buprenorphine/naloxone. HHS mistakenly listed the American Osteopathic Academy of Addiction Medicine (AOAAM) as an approved credentialing organization when they intended to reference the American Osteopathic Association (AOA). (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - September 9, 2016 Category: Rural Health Source Type: news

Words matter: The language of addiction and life-saving treatments
News articles, radio, and television frequently report on the current opioid crisis. As the death toll has mounted, the media has importantly covered many aspects of the crisis. Unfortunately, this coverage often focuses on the very visible individuals who continue to struggle with active addiction. What is missing is a narrative of hope for a chronic disease which is as treatable as diabetes or high blood pressure. In addition to the pessimistic portrait painted about addiction, the language used by the media is often problematic. Articles frequently use the term “abuse” or “abuser” or refer to ind...
Source: New Harvard Health Information - August 15, 2016 Category: Consumer Health News Authors: Sarah Wakeman, MD, FASAM, Medical Director, Massachusetts General Hospital Substance Use Disorder Initiative Tags: Addiction Behavioral Health Pain Management Source Type: news

Some good news on opioid epidemic: Treatment options are expanding
This article was originally published on The Conversation. Read the original article. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - August 10, 2016 Category: Consumer Health News Source Type: news

Fentanyl: The dangers of this potent “ man-made ” opioid
As we watch the devastation of the opioid crisis escalate in a rising tide of deaths, a lesser known substance is frequently mentioned: fentanyl. Fentanyl’s relative obscurity was shattered with the well-publicized overdose death of pop star Prince. Previously used only as a pharmaceutical painkiller for crippling pain at the end of life or for surgical procedures, fentanyl is now making headlines as the drug responsible for a growing proportion of overdose deaths. So what is fentanyl and why is it so dangerous? Fentanyl is a synthetic opioid, meaning it is made in a laboratory but acts on the same receptors in the b...
Source: New Harvard Health Information - August 5, 2016 Category: Consumer Health News Authors: Sarah Wakeman, MD, FASAM, Medical Director, Massachusetts General Hospital Substance Use Disorder Initiative Tags: Addiction Behavioral Health Brain and cognitive health Pain Management Prevention Source Type: news

Suboxone (Buprenorphine HCl and naloxone HCl) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 25, 2016 Category: Drugs & Pharmacology Source Type: news

Bunavail (Buprenorphine and Naloxone Buccal Film) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 22, 2016 Category: Drugs & Pharmacology Source Type: news

Opioid abusers missing out on addiction-fighting drug
Dennis Thompson, HealthDay News Doctors aren't using one of the most effective weapons in battling addiction to prescription painkillers -- the anti-addiction drug Suboxone, a new study finds. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 20, 2016 Category: Consumer Health News Source Type: news

Suboxone Underused, Opioids Overused in Medicare
(MedPage Today) -- Medicare patients who are addicted to opioids may not be getting the help they need (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - July 20, 2016 Category: Geriatrics Source Type: news

Study examines opioid agonist therapy use in Medicare patients
Few Medicare enrollees appear to be receiving buprenorphine-naloxone, the only opioid agonist therapy for opioid addiction available through Medicare Part D prescription drug coverage, according to a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 20, 2016 Category: Science Source Type: news

Opioid Abusers Missing Out on Addiction-Fighting Drug
WEDNESDAY, July 20, 2016 -- Doctors aren't using one of the most effective weapons at their disposal in battling addiction to prescription painkillers -- the anti-addiction drug Suboxone, a new study finds. A review of Medicare claims showed that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 20, 2016 Category: Journals (General) Source Type: news

Treating Drug Addiction With Drugs
The old saying goes that you have to fight fire with fire. Using that logic, health officials have increased the availability of an opioid to combat the rising tide of opiate addiction. On any given day, according to the U.S. Centers for Disease Control and Prevention (CDC), 650,000 opioid prescriptions are dispensed. Of these, 3,900 people begin using the drugs for nonmedical reasons, and 78 people die from an opioid-related overdose. That's every day. In western Pennsylvania, for instance, deaths caused by opioids, including heroin and prescription drugs, increased by more than a third last year, according to a new r...
Source: Healthy Living - The Huffington Post - July 18, 2016 Category: Consumer Health News Source Type: news

How one physician uses his PDMP to help patients
Prescription drug monitoring programs (PDMP) can be an effective clinical tool to assist physicians in making prescribing decisions. Effective PDMPs can help identify red flags in prescription use, and provide information when assessing and making treatment decisions. Learn how one physician in New York uses his PDMP to inform treatment options and discuss safety issues with patients. What a PDMP can do for patients and physicians “The bottom line is that New York’s PDMP is a good tool to use to get some information for your assessment and discussion with your patient,” said Frank Dowling, MD, clinica...
Source: AMA Wire - July 10, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news

HHS: Medication Assisted Treatment for Opioid Use Disorders
This final rule increases access to treatment with buprenorphine and buprenorphine/naloxone, allows eligible practitioners to request approval to treat up to 275 patients, and includes requirements to minimize the risk that medications provided for treatment will be misused or diverted. This rule is effective August 8, 2016. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - July 8, 2016 Category: Rural Health Source Type: news

Portland addictions specialists welcome Feds’ move to ease treatment restrictions
The Obama administration announced it is expanding access to a drug used to treat opioid addiction by raising the cap on how many patients a doctor can treat. Doctors will soon be able to treat 275 patients at a time with buprenorphine, up from 100 currently. The drug, which goes by the brand name Suboxone, helps patients control withdrawal symptoms and cravings for prescription painkillers and heroin alike but doesn’t get them high. About 650,000 Americans received buprenorphine in 2014, according… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 6, 2016 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Mundipharma and Orexo to launch opioid dependence treatment Zubsolv outside US
Mundipharma has signed an agreement with Swedish-based pharmaceutical company Orexo to grant exclusive global (ex-US) rights to Mundipharma’s network of independent associated companies for Zubsolv (buprenorphine and naloxone sublingual tablet), for … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 3, 2016 Category: Pharmaceuticals Source Type: news

Addiction Medicine, Meet Physician Assistants
At the recent 2016 annual meeting of the American Academy of PAs (AAPA), the AAPA House of Delegates passed two important resolutions related to the treatment of opioid addiction and the safe prescribing of opiates for pain. The first resolution promotes increased patient access to opiate treatment programs, as well as the full utilization of PAs in opiate treatment programs, submitted by my specialty organization, the Society of Physician Assistants in Addiction Medicine (SPAAM). The second resolution offers guidance to PAs for safe opioid prescribing in the context of the nationwide explosion in opiate-prescribing deaths...
Source: Healthy Living - The Huffington Post - June 29, 2016 Category: Consumer Health News Source Type: news

Addiction Treatment Industry Worried Lax Ethics Could Spell Its Doom
FORT LAUDERDALE, Fla. -- The premier organization representing drug treatment providers met in South Florida recently for its annual convention. The theme of this year's gathering -- “The Addiction Industry at a Crossroads” -- only hinted at the internal tensions and external pressures reshaping a troubled industry. The opioid epidemic, which just added Prince to its list of victims, has shoved the addiction industry into the spotlight, and many here at the National Association of Addiction Treatment Providers conference worried aloud how the industry’s lax ethical standards would look in the ne...
Source: Healthy Living - The Huffington Post - June 17, 2016 Category: Consumer Health News Source Type: news

Outdated restrictions 'barrier' to fixing B.C.s overdose crisis, report says
A new report blames B.C.'s College of Physicians and Surgeons for not lifting "barriers" to Suboxone, a prescription drug that could dramatically reduce overdose deaths amid a public health emergency. (Source: CBC | Health)
Source: CBC | Health - June 2, 2016 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

9 Things You Should Know If Your Child Is Using Heroin
This article was originally published by The Influence, a news site that covers the full spectrum of human relationships with drugs. Follow The Influence on Facebook or Twitter. References: 1. Huddleston, West, Doug Marlowe and Rachel Casebolt. Painting the Current Picture: A National Report Card on Drug Courts and Other Problem-Solving Court Programs in the United States, National Drug Court Institute 2(1), 2008 2. Jennifer Murphy, Illness or Deviance? Drug Courts, Drug Treatment, and the Ambiguity of Addiction, 2008 3. Ralph E. Tarter et al, "Predictors of Marijuana Use in Adolescents Before and After Licit Drug U...
Source: Healthy Living - The Huffington Post - May 13, 2016 Category: Consumer Health News Source Type: news

Correlates of nine-month retention following interim buprenorphine-naloxone treatment in opioid dependence: a pilot study - Hå, Kansson A, Widinghoff C, Abrahamsson T, Gedeon C.
Interim medication-only treatment has been suggested for the initiation of opioid maintenance treatment (OMT) in opioid-dependent subjects, but this rarely has been studied using buprenorphine instead of methadone. Following a pilot trial assessing interim... (Source: SafetyLit)
Source: SafetyLit - April 14, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Factors associated with non-adherence to Buprenorphine-naloxone among opioid dependent African-Americans: a retrospective chart review - Kumari S, Manalai P, Leong S, Wooditch A, Malik M, Lawson WB.
Background and Objectives Opioid use disorders are common, chronic relapsing disorders. Buprenorphine (BUP) is an FDA approved medication in the treatment of opioid use disorders, but patient adherence to this medication remains a challenge. To identify... (Source: SafetyLit)
Source: SafetyLit - April 2, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

A monthly shot for opioid addiction: An option for some
On average, 44 people in the United States die every day from an overdose of opioid prescription painkillers. These drugs — such as Vicodin, Percocet, codeine, and morphine — reduce the brain’s recognition of pain by binding to certain receptors in the body. With continued use, a person can develop a physical dependence on these drugs, such that withdrawal symptoms occur if the drug is stopped. These drugs can also cause a “high.” Both of these effects contribute to addiction — that is, the loss of control around the use of a drug, even though it causes harm to the person. Addiction to o...
Source: New Harvard Health Information - April 1, 2016 Category: Consumer Health News Authors: Wynne Armand, MD Tags: Addiction Behavioral Health Mental Health Source Type: news

How Obama’s opioid initiatives align with physician recommendations
An AMA Viewpoints post by Patrice A. Harris, MD, chair-elect of the AMA Board of Trustees As a nation, we are working incredibly hard to turn the course of the opioid epidemic in a new direction. This week I had the great pleasure to be part of an event that focused on hope, possibilities and action. President Obama announced new initiatives that would expand access to treatment for substance use disorder, among other important actions that align with measures we physicians have recommended. The president’s initiatives, announced Tuesday at the National Rx Drug and Heroin Abuse Summit in Atlanta, combin...
Source: AMA Wire - March 31, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news

How Obama ’s opioid initiatives align with physician recommendations
An   AMA Viewpoints   post by Patrice A. Harris, MD, chair-elect of the AMA Board of Trustees As a nation, we are working incredibly hard to turn the course of the opioid epidemic in a new direction. This week I had the great pleasure to be part of an event that focused on hope, possibilities and action. President Obama announced new initiatives that would expand access to treatment for substance use disorder, among other important actions that align with measures we physicians have recommended. The president ’s initiatives, announced Tuesday at the National Rx Drug and Heroin Abuse Summit in Atlant...
Source: AMA Wire - March 31, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news